Abstract Background and Objectives To evaluate the toxicity and efficacy of stereotactic body
radiotherapy (SBRT) for the treatment of localized hepatocellular carcinoma (HCC) in the …

Purpose To describe efficacy and safety of stereotactic body radiation therapy (SBRT) for the
treatment of inoperable hepatocellular carcinoma. Methods The records of 77 consecutive …

Purpose To describe outcomes of prospective trials of stereotactic body radiotherapy (SBRT)
for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients …

PURPOSE: To evaluate the safety and efficacy of stereotactic body radiotherapy (SBRT) for
the treatment of primary hepatocellular carcinoma (HCC). METHODS AND MATERIALS …

Background Although several prospective studies have reported the efficacy of stereotactic
body radiotherapy (SBRT) for hepatocellular carcinoma (HCC), treatment‐related toxicity …

Abstract Background Stereotactic Body Radiation Therapy (SBRT) is a non-invasive ablative
treatment for hepatocellular carcinoma (HCC). This report aimed to address the limited …

Objectives To evaluate the feasibility and efficacy of stereotactic body radiation therapy
(SBRT) in the treatment of hepatocellular carcinoma (HCC) unsuitable for standard loco …

Background and purpose Stereotactic body radiotherapy (SBRT) is an emerging ablative
modality for hepatocellular carcinoma (HCC). This study aimed to synthesize available …

Background Recent studies using stereotactic body radiotherapy (SBRT) for hepatocellular
carcinoma (HCC) have reported high tumor response and local control. However, the …

Methods A phase II, single-arm clinical trial on SBRT for small HCCs was conducted at an
academic tertiary care center. The planned SBRT dose was 45 Gy with a fraction size of 15 …